Where Does Wall Street Think FibroGen Inc (FGEN) Stock Will Go?

Tuesday, September 26, 2023 01:44 PM | InvestorsObserver Analysts

Mentioned in this article

InvestorsObserver is giving FibroGen Inc (FGEN) an Analyst Rating Rank of 2, meaning FGEN is ranked higher by analysts than 2% of stocks. The average price target for FGEN is $2.166 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating FGEN a Hold today. Find out what this means to you and get the rest of the rankings on FGEN!
See Full FGEN Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With FibroGen Inc Stock Today?

FibroGen Inc (FGEN) stock has gained 3.38% while the S&P 500 is down -1.36% as of 1:44 PM on Tuesday, Sep 26. FGEN is up $0.03 from the previous closing price of $0.84 on volume of 3,120,418 shares. Over the past year the S&P 500 has gained 17.05% while FGEN is down -92.85%. FGEN lost -$3.39 per share the over the last 12 months. Click Here to get the full Stock Report for FibroGen Inc stock.

Share this article:

Related Articles